Literature DB >> 8851623

Influence of experimental rat model of multiple organ dysfunction on cefepime and amikacin pharmacokinetics.

O Mimoz1, A Jacolot, C Padoin, J Quillard, M Tod, K Louchahi, K Samii, O Petitjean.   

Abstract

We adapted an experimental model of multiple organ dysfunction to study the alterations it induces in the pharmacology of cefepime and amikacin. The half-lives of both antibiotics were significantly prolonged because of nonsignificant enhancement of the volume of distribution and reduced renal elimination. In the presence of multiple organ dysfunction, the concentration of each antibiotic in the lungs, compared with that in the lungs of healthy controls, was significantly decreased, despite similar concentrations in plasma, indicating that the application of a standard antibiotic concentration in plasma could lead to underdosage in tissues during the initial days of therapy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8851623      PMCID: PMC163210     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

Review 1.  Influence of fever on pharmacokinetics.

Authors:  P A Mackowiak
Journal:  Rev Infect Dis       Date:  1989 Sep-Oct

Review 2.  Antibiotic tissue penetration and its relevance: models of tissue penetration and their meaning.

Authors:  D E Nix; S D Goodwin; C A Peloquin; D L Rotella; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

3.  High-pressure liquid chromatographic analysis of BMY-28142 in plasma and urine.

Authors:  R H Barbhaiya; S T Forgue; W C Shyu; E A Papp; K A Pittman
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

4.  Capillary permeability in septic patients.

Authors:  H Ellman
Journal:  Crit Care Med       Date:  1984-08       Impact factor: 7.598

Review 5.  Sepsis and septic shock--a review of laboratory models and a proposal.

Authors:  K A Wichterman; A E Baue; I H Chaudry
Journal:  J Surg Res       Date:  1980-08       Impact factor: 2.192

6.  Gentamicin volume of distribution in critically ill septic patients.

Authors:  C Triginer; I Izquierdo; R Fernández; J Rello; J Torrent; S Benito; A Net
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

7.  Sustained hypermetabolic sepsis in rats: characterization of the model.

Authors:  C H Lang; G J Bagby; G H Bornside; L J Vial; J J Spitzer
Journal:  J Surg Res       Date:  1983-09       Impact factor: 2.192

8.  Altered aminoglycoside pharmacokinetics in critically ill patients with sepsis.

Authors:  H J Mann; D W Fuhs; R Awang; F A Ndemo; F B Cerra
Journal:  Clin Pharm       Date:  1987-02

9.  Altered aminoglycoside pharmacokinetics in the critically ill.

Authors:  M J Beckhouse; I M Whyte; P L Byth; J C Napier; A J Smith
Journal:  Anaesth Intensive Care       Date:  1988-11       Impact factor: 1.669

10.  Multiple-organ failure and sepsis without bacteria. An experimental model.

Authors:  R J Goris; W K Boekholtz; I P van Bebber; J K Nuytinck; P H Schillings
Journal:  Arch Surg       Date:  1986-08
View more
  1 in total

1.  Pharmacodynamics, a tool for a better use of antibiotics?

Authors:  F Crokaert
Journal:  Intensive Care Med       Date:  2001-02       Impact factor: 17.440

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.